Hymovis™ Versus Placebo in Knee Osteoarthritis

Completed · Phase 3 · Has a placebo group

Conditions studied: Knee Osteoarthritis

In brief

Purpose: The purpose of this study is to demonstrate if the intra-articular injection of a new viscoelastic Hydrogel (Hymovis) is superior to Placebo (phosphate buffered saline \[PBS\] in subjects with symptomatic osteoarthritis of the knee.

Key facts

Study ID
NCT01372475
Run by
Fidia Farmaceutici s.p.a.
People needed
800
Starts
2011-03-01
Expected to finish
2013-02-01
Last updated by the study team
2014-04-08

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.